The Company, Yatharth Hospital & Trauma Care Services Limited, proposes to issue securities by way of a preferential issue on a private placement basis to Rasmalai Limited, a company incorporated under the laws of Cyprus.
The aggregate cash consideration for the issue is approximately INR 31,500 million (~₹3,150 crore).
The securities to be issued shall represent a minority investment of 24.87% of the post-issue share capital of the Company on a fully diluted basis.
The Investor, Rasmalai Limited, has a Permanent Account Number (PAN) in India: AANCD0341F.
Regulatory Approval Status
The Competition Commission of India (CCI) has approved the proposed combination (transaction) under Section 31(1) of the Competition Act, 2002.
The approval was granted in the CCI's meeting held on November 10, 2026, vide a letter of the same date (enclosed with the filing).
The CCI's formal order regarding this approval will be issued separately.
The proposed transaction remains subject to the fulfilment of other applicable regulatory and statutory requirements.
Background and References
The initial notice for this transaction was filed by Rasmalai Limited with the CCI on September 29, 2026, under sub-section (2) of Section 6 of the Competition Act, 2002.
The CCI assigned a registration number to this filing: C-2026/09/1477.
The company had previously informed the exchanges of its intention to undertake this preferential issue via a notice dated September 22, 2026 (Letter No. YH/SE/51/2026-27).
Document and Company Information
Scrip Code (NSE): YATHARTH | ISIN: INE0JO301016
The disclosure is also available on the company's website at https://www.yatharthhospitals.com/investors/corporate-announcements.
